Humacyte, Inc. to Present at the TD Cowen 44th Annual Health Care Conference

March 1, 2024

https://www.globenewswire.com/news-release/2024/03/01/2838873/0/en/Humacyte-Inc-to-Present-at-the-TD-Cowen-44th-Annual-Health-Care-Conference.html

DURHAM, N.C., March 01, 2024 (GLOBE NEWSWIRE) — Humacyte, Inc. (Nasdaq:HUMA), a clinical-stage biotechnology platform company developing universally implantable, bioengineered human tissue at commercial scale, today announced that Laura Niklason, M.D., Ph.D., Founder, President, and Chief Executive Officer, and Dale Sander, Chief Financial Officer, will present at the TD Cowen 44th Annual Health Care Conference, in Boston, MA on Monday, March 4, 2024. Management will also be available for one-on-one meetings.

Read more at globenewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.